NCT06764329View on ClinicalTrials.gov

The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.

PHASE1/PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

December 25, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 30, 2025

Conditions
Androgenetic AlopeciaAndrogenetic Alopecia (AGA)
Interventions
BIOLOGICAL

Mesenchymal Stem Cells

allogeneic bone marrow-derived mesenchymal stem cells therapy

OTHER

0.9 % saline

0.9% Saline as placebo

Trial Locations (2)

46000

Department of dermatology, Pak-Emirates Military Hospital, Rawalpindi

National Institute of Blood and Marrow Transplant (NIBMT), Rawalpindi

All Listed Sponsors
collaborator

Pak Emirates Military Hospital

OTHER

lead

National Institute of Blood and Marrow Transplant (NIBMT), Pakistan

OTHER_GOV